Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-6512
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations ; volume:10 ; number:1 ; day:21 ; month:11 ; year:2019 ; pages:1-13 ; date:12.2019
Stem cell research & therapy ; 10, Heft 1 (21.11.2019), 1-13, 12.2019
- Urheber
-
Moradi, Sharif
Mahdizadeh, Hamid
Šarić, Tomo
Kim, Johnny
Harati, Javad
Shahsavarani, Hosein
Greber, Boris
Moore, Joseph B.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-019-1455-y
- URN
-
urn:nbn:de:101:1-2020031800520379180615
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moradi, Sharif
- Mahdizadeh, Hamid
- Šarić, Tomo
- Kim, Johnny
- Harati, Javad
- Shahsavarani, Hosein
- Greber, Boris
- Moore, Joseph B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lucky iPSCs
iPSCs are safe!
Complex regulatory networks influence pluripotent cell state transitions in human iPSCs
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs)
Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs)
Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs)
Modelling urea cycle disorders using iPSCs
Induced Pluripotent Stem Cells (iPSCs) in Vascular Research: from Two- to Three-Dimensional Organoids
Current challenges in the therapeutic use of induced pluripotent stem cells (iPSCs) in cancer therapy
Transcriptome-level assessments and computational characterization of disease models based on induced pluripotent stem cells (iPSCs)
Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs)
Lucky iPSCs
iPSCs are safe!
Complex regulatory networks influence pluripotent cell state transitions in human iPSCs
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs)
Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs)
Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs)
Modelling urea cycle disorders using iPSCs
Induced Pluripotent Stem Cells (iPSCs) in Vascular Research: from Two- to Three-Dimensional Organoids
Current challenges in the therapeutic use of induced pluripotent stem cells (iPSCs) in cancer therapy
Transcriptome-level assessments and computational characterization of disease models based on induced pluripotent stem cells (iPSCs)
Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs)
Lucky iPSCs
iPSCs are safe!
Complex regulatory networks influence pluripotent cell state transitions in human iPSCs
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs)
Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs)
Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs)
Modelling urea cycle disorders using iPSCs
Induced Pluripotent Stem Cells (iPSCs) in Vascular Research: from Two- to Three-Dimensional Organoids
Current challenges in the therapeutic use of induced pluripotent stem cells (iPSCs) in cancer therapy
Transcriptome-level assessments and computational characterization of disease models based on induced pluripotent stem cells (iPSCs)